Accordingly, BTK inhibition by ibrutinib, acalabrutinib and zanubrutinib effectively suppressed MM-mediated induction of CXCL13 mRNA levels in macrophages co-cultured with MM cells (Fig. 4B). The gene discussed is CXCL13; the disease is Miyoshi myopathy.